Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system

The 2016 revised fourth edition of the World Health Organization (WHO) classification of central nervous system (CNS) tumors incorporated molecular features with histologic grading, revolutionizing how oncologists conceptualize primary brain and spinal cord tumors as well as providing new insights i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer Jg. 128; H. 1; S. 47 - 58
Hauptverfasser:	Gritsch, Simon, Batchelor, Tracy T., Gonzalez Castro, L. Nicolas
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Wiley Subscription Services, Inc 01.01.2022
Schlagworte:	2021 World Health Organization (WHO) central nervous system (CNS) tumor classification Adult Astrocytoma Brain cancer Brain Neoplasms - diagnosis Brain Neoplasms - therapy Brain tumors Central nervous system Central Nervous System - pathology Central Nervous System Neoplasms - diagnosis Central Nervous System Neoplasms - genetics Central Nervous System Neoplasms - therapy Child Classification Clinical trials glioblastoma Glioma Glioma - pathology Humans isocitrate dehydrogenase (IDH)‐mutant gliomas Isocitrate Dehydrogenase - genetics Medical diagnosis Medical prognosis meningiomas Mutation Nervous system Oncology Pathophysiology Pediatrics Prognosis Spinal cord Tumors World Health Organization glioma 2021 World Health Organization (WHO) central nervous system (CNS) tumor classification glioblastoma meningiomas isocitrate dehydrogenase (IDH)-mutant gliomas
ISSN:	0008-543X, 1097-0142, 1097-0142
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!